Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
https://vimeo.com/253656312
This video is a few months old but gives a great (if slightly technical) introduction to Lygenesis. Phase 2 trials to start next year, skipping phase 1 altogether such is the need for this technology. Huge potential and Juvenescence owns 30%.
https://www.eurekalert.org/pub_releases/2019-06/imi-imu060619.php
Chils, that's a sensible post. The only thing I would add though is that Intensity probably has a better chance of success than your average private company developing a new cancer drug, for the following reasons:
Intensity's approach is not to trial a new drug, but to take proven chemotherapy drugs and deliver them in a much more effective way directly to the tumour, which results in fewer side effects, thoroughly destroys the tumour and stimulates an immune response. Safety does not appear to be an issue so it's just a question of how effective the treatment is at higher doses, but so far it's looking very promising, even at low doses.
Leap upon sale/IPO and Emmac upon IPO could each be worth our current market cap. Intensity could be multiples upon a buy out if results continue to be good. Then there's Factom, Juvenescence, and Regent Pacific (if the deal goes through) each with enormous potential long term.
There seems to be a gradual trend towards FFWD investing in life-science funds which reduces risk but maintains focus on the huge longevity and wellness market. Bargain price at present.
https://player.fm/series/the-bio-report-49047/a-treat-locally-act-globally-strategy-for-treating-cancer
After another sh-tty week for the share price here is an interview which may just restore you faith in FFWD. This could be the investment which finally blows the sp out of the water.
It's a few weeks old now but Lew Bender of Intensity gives this really inspiring interview, as well as hope to millions!
https://www.prnewswire.co.uk/news-releases/regent-pacific-enters-exploding-cbd-market-in-asia-through-proposed-acquisition-of-yooya-882370972.html
Now it's had time to sink in it's looking very interesting indeed and the overall picture is becoming clearer.
Also if you really believe in the Yooya story, there is RP you can invest in directly now for 100% of Yooya.
On the face of it it's a disappointing valuation for Yooya considering all the 'YouTube' analogy rhetoric, but trying to put a positive spin on things, if the deal does go through we'll have more control over exiting, and in the meantime we take on Plethora as a new investment also which adds to the Life Science mix. Let's hope there is least one unicorn left amongst our portfolio.
Cheers for the tip Jesterman.
It's ok Jesterman I've just spotted that Pam Martin is with Selftrade. Yes I will certainly contact her if there is no resolution soon. There is another lady from Selftrade who I'm liaising with also at the moment who is trying to resolve the issue, but I might well take this matter to the top if it's not sorted out soon.
Hi Jesterman, thanks for your reply. Is Pam Martin the Customer Services Centre Manager of Selftrade or Portage? Have you experienced any problems in receiving the share certificates yourself? I just wondered how you know who to contact. Thanks again.
I'd be interested to know of any other SALV shareholders who have not yet received their Portage shares, particularly any who use Selftrade. I've contacted Selftrade several times as well as emailed Portage for some clarification. Portage have told me that the share certificates were dispatched back in Jan, but Selftrade's nominees have confirmed that the certificates never arrived, hence lost in transit apparently!! If this is true it's clearly very concerning. I'm still waiting for further clarification.
If you haven't yet received your share certificate, I would strongly recommend you contact your broker too and confirm whether your nominees have actually received the shares from the Portage Registrars in Canada.
Would appreciate any comments on this.
Chilston, when was the last time you posted a link of interest to FFWD shareholders, or for that matter anything remotely interesting or useful? No.. I can't find it either!
Forward 15 mins for Paul Snow. There's even a brief mention of Yooya after 59 mins, so at least we know Yooya hasn't disappeared entirely into a black hole!
update by Paul Snow. Not sure whether this has been posted or not.
https://www.youtube.com/watch?v=0KY1bQGFmd0
http://www.pharmatimes.com/news/insilico,_ark_initiate_health-span_and_longevity_partnership_1288969
If the link won't open just google insilico and you'll find it anyway.
http://www.pharmatimes.com/news/insilico,_ark_initiate_health-span_and_longevity_partnership_1288969
For me the consideration of whether to hold Leap boils down to how much more mileage we can get from it. Being our largest stake by far it would be worth holding if the % returns over the next couple of years are as good as we can expect from other investments, but I suspect the growth momentum won't be as good as with a life science investment. I would be disappointed if we got anything less than £10 million for Leap.
Blue is the colour, Leap is the game, we're all waiting patiently, and winning is our aim.
Nice find Mat. Just the tonic investors need right now. Germany the biggest market in Europe.